Rigel Pharmaceuticals (RIGL) EBIT Margin Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -40,178.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 530.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1,211.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 6,993.00 |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn | 6,902.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,902.00 |
| Dec 31, 2025 | 2,914.00 |
| Sep 30, 2025 | 12,303.00 |
| Jun 30, 2025 | 10,357.00 |
| Mar 31, 2025 | 18,087.00 |
| Dec 31, 2024 | 13,386.00 |
| Sep 30, 2024 | 11,725.00 |
| Jun 30, 2024 | 5,089.00 |
| Mar 31, 2024 | -7,512.00 |
| Dec 31, 2023 | 10,754.00 |
| Sep 30, 2023 | 5,907.00 |
| Jun 30, 2023 | 8,897.00 |
| Mar 31, 2023 | -8,652.00 |
| Dec 31, 2022 | 11,663.00 |
| Sep 30, 2022 | -2,441.00 |
| Jun 30, 2022 | 16,157.00 |
| Mar 31, 2022 | -1,134.00 |
| Dec 31, 2021 | -11,163.00 |
| Sep 30, 2021 | 40,909.00 |
| Jun 30, 2021 | 141,149.00 |
| Dec 31, 2020 | -68,668.00 |
| Sep 30, 2020 | 190,895.00 |
| Mar 31, 2020 | 48,977.00 |
| Dec 31, 2019 | 41,366.00 |
| Sep 30, 2019 | 54,705.00 |
| Jun 30, 2019 | -4,624.00 |
| Mar 31, 2019 | 20,373.00 |
| Dec 31, 2018 | 15,600.00 |
| Sep 30, 2018 | -44,875.00 |
| Jun 30, 2018 | -119,160.00 |
| Dec 31, 2016 | -23,156.00 |
| Jun 30, 2016 | 147,583.00 |
| Jun 30, 2015 | 138,924.00 |
| Mar 31, 2015 | 227,049.00 |
| Jun 30, 2013 | -168,919.00 |